Ragweed Major Allergen Amb a 11 Recombinant Production and Clinical Implications
Biomolecules · 2023
DOI: 10.3390/biom13010182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Tudor-Paul Tamaș und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center of Immuno-Physiology and Biotechnologies, Department of Functional Sciences, Victor Babes University of Medicine and Pharmacy, 300041 Timișoar…. Hauptthemen laut MEDLINE: Hypersensitivity, Asthma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund under Competitiveness Operational Programme 2014-2020, Priority Axis 1 "Research, Technological Development and Innovation (…, INSPIRED (Innovative Strategies for Prevention, Diagnosis, and Therapy of Ragweed-Pollen-Induced Respiratory Diseases) project.
Abstract (Originalsprache)
Ragweed pollen is highly allergenic and elicits type I hypersensitivity reactions in the exposed populations. Amb a 11 is a recently discovered component of this pollen, and its biological role in allergy is still being researched. In our study, ragweed allergy patients were recruited prospectively over a three-year period; a comprehensive questionnaire was administered, and sera were collected and stored. The production of recombinant Amb a 11 was achieved in parallel with patients’ recruitment. The gene coding for mature protein was inserted in E. coli and in Sf9 Spodoptera frugiperda cells. The recombinant allergens (designated eAmb a 11 and iAmb a 11) were tested for His-tag presence in Western blot. IgE reactivity was evaluated in 150 patients’ sera for both recombinant allergen forms in ELISA, with 5 positive sera being tested further by hRBL (humanized rat basophilic leukemia) hexosaminidase release assay. Both allergen forms were proven to be IgE-reactive His-tagged proteins, with an extensive overlap of positive sera (92 toward the former recombinant allergen, 100 toward the latter) and an overall Amb a 11 sensitization prevalence estimated at 68.67%. The hRBL mediator release assay revealed a significant, slightly weaker effect of recombinant allergens when compared with nAmb a 1. Sensitization to this major allergen appears to be associated with more severe asthma symptoms (OR = 4.71, 95% CI = 1.81–12.21). In conclusion, recombinant Amb a 11 is a bona fide allergen, which is IgE-reactive and an inducer of hRBL degranulation. It is an important IgE-reactive component from ragweed pollen, with high IgE sensitization prevalence in the sample population and allergenicity of the recombinant allergen comparable to Amb a 1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Immuno-Physiology and Biotechnologies, Department of Functional Sciences, Victor Babes University of Medicine and Pharmacy, 300041 Timișoara, Romania.
- OncoGen Center, "Pius Brînzeu" Timiș County Clinical Emergency Hospital, 300723 Timișoara, Romania.
ORCID-Profile: Tudor-Paul Tamaș, Maria-Roxana Buzan, Carmen Panaitescu
Förderung
- European Regional Development Fund under Competitiveness Operational Programme 2014-2020, Priority Axis 1 "Research, Technological Development and Innovation (…
- INSPIRED (Innovative Strategies for Prevention, Diagnosis, and Therapy of Ragweed-Pollen-Induced Respiratory Diseases) project
Zitieren
APA
Tamaș, T. P., Buzan, M. R., Zbîrcea, L. E., Cotarcă, M. D., Grijincu, M., Păunescu, V., Panaitescu, C., & Chen, K. W. (2023). Ragweed Major Allergen Amb a 11 Recombinant Production and Clinical Implications. Biomolecules. https://doi.org/10.3390/biom13010182
Vancouver
Tamaș TP, Buzan MR, Zbîrcea LE, Cotarcă MD, Grijincu M, Păunescu V, et al. Ragweed Major Allergen Amb a 11 Recombinant Production and Clinical Implications. Biomolecules. 2023. doi:10.3390/biom13010182
BibTeX
@article{Tama2023,
author = {Tamaș, Tudor-Paul and Buzan, Maria-Roxana and Zbîrcea, Lauriana-Eunice and Cotarcă, Monica-Daniela and Grijincu, Manuela and Păunescu, Virgil and Panaitescu, Carmen and Chen, Kuan-Wei},
title = {Ragweed Major Allergen Amb a 11 Recombinant Production and Clinical Implications},
journal = {Biomolecules},
year = {2023},
doi = {10.3390/biom13010182}
}
EUVIMED